Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  CompuGroup Medical Societas Europaea    COP   DE0005437305

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

CompuGroup Medical : acquires eMDs

11/23/2020 | 02:10am EST

DGAP-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Mergers & Acquisitions
CompuGroup Medical SE & Co. KGaA acquires eMDs

23-Nov-2020 / 08:08 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Today, CompuGroup Holding USA, Inc., a 100 % subsidiary of CompuGroup Medical SE & Co. KGaA ("Company"), and MDeverywhere Midco, Inc., USA, the sole indirect shareholder of eMDs, Inc., USA (jointly "eMDs"), have entered into an agreement regarding acquisition of 100 % issued and outstanding capital stock of eMDs. The competent corporate bodies of the Company have already approved the transaction.

eMDs' key products are Ambulatory Information Systems and outsourcing services for the accounting of medical services. CGM is thus strengthening its position in the USA significantly and, after the acquisition, will be the top 4 in the market for Ambulatory Information Systems in the USA based on the number of independent doctors' practices which are not part of a hospital.

The transaction is structured as a reverse triangular merger under U.S. law. The consideration to be paid to the current shareholders of eMDs is based on an enterprise value of approx. USD 240 million (approx. EUR 203 million), which will be adjusted inter alia for amounts of cash, financial debt and net working capital (compared to a reference amount) as of the closing date. In the fiscal year 2019/2020 (ended 2020/03/31), eMDs generated revenues of approx. EUR 81 million and an EBITDA of approx. EUR 12 million with more than 60.000 healthcare providers.

Closing of the transaction is expected by the end of 2020 and is in particular subject to approvals by the U.S. merger control and investment control authorities.


23-Nov-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)261 8000 7030
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1149807

 
End of Announcement DGAP News Service

1149807  23-Nov-2020 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1149807&application_name=news&site_id=zonebourse_sftp

© EQS 2020
All news about COMPUGROUP MEDICAL SOCIETAS EUROPAEA
2020COMPUGROUP MEDICAL : successfully completes acquisition of eMDs in the USA
EQ
2020COMPUGROUP MEDICAL SE & CO. KGAA : Notification and public disclosure of transac..
EQ
2020COMPUGROUP MEDICAL : Deutsche Bank remains its Buy rating
MD
2020COMPUGROUP MEDICAL : Berenberg reiterates its Neutral rating
MD
2020COMPUGROUP MEDICAL : expects revenues of EUR 1 billion in 2021 and invests in gr..
PU
2020COMPUGROUP MEDICAL : Baader Bank maintains a Sell rating
MD
2020COMPUGROUP MEDICAL : Warburg Research gives a Neutral rating
MD
2020COMPUGROUP MEDICAL : expects revenues of EUR 1 billion in 2021 and invests in gr..
EQ
2020COMPUGROUP MEDICAL : Gets a Buy rating from Warburg Research
MD
2020COMPUGROUP MEDICAL : Baader Bank maintains a Sell rating
MD
More news
Financials
Sales 2020 841 M 1 017 M 1 017 M
Net income 2020 91,8 M 111 M 111 M
Net Debt 2020 485 M 586 M 586 M
P/E ratio 2020 46,2x
Yield 2020 0,63%
Capitalization 4 361 M 5 266 M 5 269 M
EV / Sales 2020 5,76x
EV / Sales 2021 4,80x
Nbr of Employees 5 904
Free-Float 50,0%
Chart COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | COP | DE0005437305 | MarketScreener
Technical analysis trends COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 82,00 €
Last Close Price 81,15 €
Spread / Highest target 10,9%
Spread / Average Target 1,05%
Spread / Lowest Target -12,5%
EPS Revisions
Managers and Directors
NameTitle
Dirk Wössner Chairman-Management Board
Philipp von Ilberg Chairman-Supervisory Board
Michael Rauch Chief Financial Officer
Hannes Reichl Director-Clinical & Social Care
Frank Gotthardt Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
COMPUGROUP MEDICAL SOCIETAS EUROPAEA3.24%5 256
ORACLE CORPORATION-4.50%181 882
SAP SE-3.71%149 044
INTUIT INC.-2.33%102 416
SERVICENOW INC.-6.66%100 209
DOCUSIGN, INC.12.14%46 505